PAGE 13			HIV NUTRITION UPDATE					VOLUME 7, ISSUE 6
		HERBAL UPDATE
	(Return to page 12)							Ancient herbal remedies are usually not researched in the U.S. and therefore remain nebulous to many people. U.S. Food and Drug Administration (FDA) approval of a phase I/II clinical trial to test the efficacy of Kanglaite in treating non-small-cell lung cancer may help to change this non-research trend. Kanglaite is the first drug derived from a traditional Chinese herbal remedy to go into clinical trials in the United States. The anti-cancer therapy is made from the Coix Seed and certified for use in China.    As more clinical drug trials on herbals are completed by pharmaceutical companies prior to their marketing in the U.S., the need for experienced TCM practitioners will increase in an effort to avoid adverse effects stemming from their use.
			"The anti-cancer therapy is made from the Coix Seed and certified for use in China."
		More information on Globalising Chinese Medicine Forward to page 14)         Copyright 2003 HIV ReSources, Inc. Sharing this newsletter in any form with non-subscribers is strictly prohibited. Library/Institution subscribers are permitted to share HIV Nutrition Update html newsletter pages with up to five (5) employees or volunteers. NO other redistribution allowed.    Please Help To Keep This Page Updated By Notifying The Webmaster If You Find A Link That's Outdated!   HIV ReSources, Inc. PO Box 39385 Fort Lauderdale, FL 33339-9385 USA   © 2003  HIV ReSources, Inc. Any use of the information presented herein is done strictly at your own risk. No responsibility is implied or intended on the part of HIV ReSources Inc, the editor, or the publisher. Information on this site should not be construed as an endorsement of any kind.   5/29/2002